With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|
|Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities||Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD||'A' Award Grants||2019||Massachusetts|
|Elucidating the Role of SETD2 in Pediatric High Grade Glioma Formation||Children's Hospital of Philadelphia / Thomas De Raedt, PhD||'A' Award Grants||2019||Pennsylvania|
|Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma||The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD||'A' Award Grants||2019||California|
|Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries||University of Utah / Anne Kirchhoff, PhD/MPH||Epidemiology Grants||2019||Utah|
|Cancer Risk and Incidence in Beckwith-Wiedemann Syndrome||Children's Hospital of Philadelphia / Jennifer Kalish, MD/PhD||Epidemiology Grants||2019||Pennsylvania|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD||Innovation Grants||2019||New York|
|CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression||Medical University of South Carolina / Meenal Mehrotra, MD/PhD||Innovation Grants||2019||South Carolina|
|Identifying targeted treatments for DICER1-associated sarcomas||Research Institute of the McGill University Health Centre / William Foulkes, MD/PhD & Sidong Huang, PhD||Innovation Grants||2019||Quebec|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|